2016 International Congress

Monday, June 20, 2016

12:30pm-2:00pm

Anti-LGI1 encephalitis presenting as a progressive supranuclear palsy-like syndrome

G.A. Da Prat, E.M. Gatto, G.G. Persi, V. Parisi, D. Lisei, L. Rattagan, M. Bres Bullrich, S. Camerlingo, C. Rugilo, M. Titulaer, G. Rojas (Caba, Argentina)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus)  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

AntiParkinsonian medication adjustments following deep brain stimulation of subthalamic nucleus in patients with advanced Parkinson’s disease

A. Gamaleya, E. Bril, A. Tomskiy, A. Poddubskaya, N. Gubareva, N. Fedorova, V. Shabalov (Moscow, Russia)

Surgical therapy: Parkinson's disease  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Anxiety and freezing of gait: A new perspective for early intervention

K.A. Ehgoetz Martens, J.M. Hall, M. Gilat, M.J. Georgiades, C.C. Walton, S.J.G. Lewis (Camperdown, Australia)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Anxiety in patients with Parkinson’s disease

K. Zhu, J.J. van Hilten, J. Marinus (Leiden, Netherlands)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Anxiolytic-like activity of the adenosine A_2A receptor antagonist, istradefylline (KW-6002) in rodent models of anxiety

K. Yamada, M. Kobayashi, J. Kase, A. Mori, P. Jenner, T. Kanda (Shizuoka, Japan)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Apathy and striatal dopamine defects in non-demented patients with Parkinson’s disease

S.J. Chung, J.J. Lee, J.H. Ham, P.H. Lee, Y.H. Sohn (Seoul, Korea)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Appendicitis and risk of Parkinson’s disease: A Danish nationwide population-based cohort study

E. Svensson, E. Horváth-Puhó, M. Stockholm, H. Toft-Sørensen, P. Borghammer (Aarhus N, Denmark)

Epidemiology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Application and correlates of the PSP quality of life scale

L.A. Higginbotham, V. Johnson, A. Pantelyat (Baltimore, MD, USA)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus)  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Application of Parkinson’s well-being map to assess impairment of digestive system in patients of Tomsk region, Russia

Y. Mironova, I. Zhukova, N. Zhukova, V. Alifirova, O. Izhboldina, A. Latypova, M. Nikitina (Tomsk, Russia)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Application of the MDS research criteria for prodromal Parkinson’s disease to the longitudinal population-based Bruneck study cohort

P. Mahlknecht, A. Gasperi, P. Willeit, S. Kiechl, H. Stockner, J. Willeit, G. Rungger, W. Poewe, K. Seppi (Innsbruck, Austria)

Epidemiology and Quality of Life